These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31773340)

  • 1. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
    Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
    Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer.
    Cheng Y; Bu D; Zhang Q; Sun R; Lyle S; Zhao G; Dong L; Li H; Zhao Y; Yu J; Hao X
    J Adv Res; 2023 Sep; 51():121-134. PubMed ID: 36351537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
    Tan IB; Ivanova T; Lim KH; Ong CW; Deng N; Lee J; Tan SH; Wu J; Lee MH; Ooi CH; Rha SY; Wong WK; Boussioutas A; Yeoh KG; So J; Yong WP; Tsuburaya A; Grabsch H; Toh HC; Rozen S; Cheong JH; Noh SH; Wan WK; Ajani JA; Lee JS; Tellez MS; Tan P
    Gastroenterology; 2011 Aug; 141(2):476-85, 485.e1-11. PubMed ID: 21684283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
    An O; Song Y; Ke X; So JB; Sundar R; Yang H; Rha SY; Lee MH; Tay ST; Ong X; Tan ALK; Ng MCH; Tantoso E; Chen L; Tan P; Yong WP;
    Cancer Res; 2021 May; 81(10):2788-2798. PubMed ID: 33558338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immune-related gene signature predicts prognosis of gastric cancer.
    Jiang B; Sun Q; Tong Y; Wang Y; Ma H; Xia X; Zhou Y; Zhang X; Gao F; Shu P
    Medicine (Baltimore); 2019 Jul; 98(27):e16273. PubMed ID: 31277152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.
    Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W
    Front Immunol; 2024; 15():1377472. PubMed ID: 38807601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel gene pairs signature in the prognosis of gastric cancer.
    Peng PL; Zhou XY; Yi GD; Chen PF; Wang F; Dong WG
    Cancer Med; 2018 Feb; 7(2):344-350. PubMed ID: 29282891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer.
    Ouyang W; Liu Y; Huang H; Tan Y; Huang Z; Jia X; Yu Y; Yao H
    Aging (Albany NY); 2024 May; 16(9):7818-7844. PubMed ID: 38700505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a prognostic and predictive 32-gene signature for gastric cancer.
    Cheong JH; Wang SC; Park S; Porembka MR; Christie AL; Kim H; Kim HS; Zhu H; Hyung WJ; Noh SH; Hu B; Hong C; Karalis JD; Kim IH; Lee SH; Hwang TH
    Nat Commun; 2022 Feb; 13(1):774. PubMed ID: 35140202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tumor endothelial cells (TEC) in gastric cancer and development of a TEC-based risk signature using single-cell RNA-seq and bulk RNA-seq data.
    Fan M; Xu X; Hu Y
    Aging (Albany NY); 2024 Jun; 16(12):10252-10270. PubMed ID: 38870270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
    Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.
    West AC; Tang K; Tye H; Yu L; Deng N; Najdovska M; Lin SJ; Balic JJ; Okochi-Takada E; McGuirk P; Keogh B; McCormack W; Bhathal PS; Reilly M; Oshima M; Ushijima T; Tan P; Jenkins BJ
    Oncogene; 2017 Sep; 36(36):5134-5144. PubMed ID: 28481875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
    Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
    J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer.
    Lee IS; Sahu D; Hur H; Yook JH; Kim BS; Goel A
    Gastric Cancer; 2021 May; 24(3):655-665. PubMed ID: 33523340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and Prognostic Value of an MicroRNA Signature for Gastric Carcinoma Undergoing Adjuvant Chemotherapy.
    Cheng X; Wei H; Zhang S; Zhang F
    DNA Cell Biol; 2021 Nov; 40(11):1428-1444. PubMed ID: 34767733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.